2022
DOI: 10.3389/fvets.2022.896689
|View full text |Cite
|
Sign up to set email alerts
|

Same Dosages of rPRV/XJ5-gI−/gE−/TK− Prototype Vaccine or Bartha-K61 Vaccine Similarly Protects Growing Pigs Against Lethal Challenge of Emerging vPRV/XJ-5 Strain

Abstract: Variant pseudorabies viruses (vPRV) have constantly emerged in China since late 2011. In the present study, a 1 × 106.0 TCID50 per-animal dosage of a commercially available Bartha-K61 vaccine and an rPRV/XJ5-gI−/gE−/TK− prototype vaccine freshly extracted from the vPRV/XJ-5 at the same dose were administered to evaluate the immune effectiveness thereof on growing pigs to prevent lethal strikes caused by vPRV/XJ-5. The results suggest that the Bartha-K61 vaccine at a dose of 1 × 106.0 TCID50 per animal and the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 25 publications
0
2
0
Order By: Relevance
“…Recently, two publications from China have documented a PRV variant XJ5; inoculation of this strain at a dose of 2 × 10 6 TCID 50 /pig intranasally could also induce respiratory symptoms as well as CNS symptoms and death in 11-12week-old pigs [26,27]. Tese characterization of abovementioned PRV variants may suggest the emergence of PRV with increased virulence in China.…”
Section: Discussionmentioning
confidence: 97%
“…Recently, two publications from China have documented a PRV variant XJ5; inoculation of this strain at a dose of 2 × 10 6 TCID 50 /pig intranasally could also induce respiratory symptoms as well as CNS symptoms and death in 11-12week-old pigs [26,27]. Tese characterization of abovementioned PRV variants may suggest the emergence of PRV with increased virulence in China.…”
Section: Discussionmentioning
confidence: 97%
“…PR control in China had been relatively stable until the emergence of PRV variant strains in 2011 where infections occurred in pigs even though the animals had been immunized with the Bartha-K61 strain [ 5 , 6 ]. The Bartha-K61 vaccine appeared to provide only suboptimal protection against these variants [ 7 , 8 ], although other studies do show adequate protection against such variants by the Bartha-K61 vaccine strain [ 9 , 10 ]. Irrespective, the generation of vaccines that antigenically more closely match emerging variant PRV strains may represent an added value to control these infections.…”
Section: Introductionmentioning
confidence: 99%